Proto Labs IncCEO says Protolabs is well-positioned to benefit from reshoring, with growing demand and heavy investment in CNC, 3D printing, and injection molding capacity.

Protolabs CEO Suresh Krishna says the company is well-positioned to benefit from the reshoring of manufacturing to the United States, even as the Trump administration considers additional semiconductor tariffs that could raise costs for imported data center equipment. Krishna noted that Protolabs serves all industries, including electronics customers like ASML, and is investing heavily to meet growing demand, with over $150 million in cash and more than $10 million invested this year in CNC machining, 3D printing, and injection molding equipment. He cited evidence of reshoring across rockets, satellites, data centers, drones, and medical devices, with clients including Medtronic, Johnson & Johnson, Boston Scientific, SpaceX, Blue Origin, Anduril, AeroVironment, and Skydio. Krishna emphasized that as manufacturing expands—the index has grown for six consecutive months—companies increasingly rely on Protolabs for supply chain resilience and capacity investment.
Proto Labs IncCEO says Protolabs is well-positioned to benefit from reshoring, with growing demand and heavy investment in CNC, 3D printing, and injection molding capacity.
ASML Holding N.V.
AeroVironment Inc
Boston Scientific Corp
Johnson & Johnson
Medtronic PLC